Physician

Sarah Tsang, MD

According to 2025 Medicare claims, Sarah Tsang, MD (NPI: 1225368087) practices family practice in the Amherst Town-Northampton, MA market, with the plurality of this provider's patient population coming from Hampshire, MA. This provider's primary affiliated billing organization is VALLEY MEDICAL GROUP, P.C. (NPI: 1912924705; TIN: 042945394) and primary practice location at 01002-2751. Tsang is affiliated with the Pioneer Valley Accountable Care, LLC (ACO ID: A5040) and C3 MSSP LLC (ACO ID: A5344), participating under the MSSP model.

Tsang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 779 traditional Medicare patients, billed 5,629 HCPCS/CPT codes, and received $180,168 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 4,451 prescription claims across 487 beneficiaries totaling $357,930 in drug costs, led by Eliquis (Apixaban). DME data shows 56 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $19,021 to $180,168. Similarly, Part D prescription costs have risen steadily, from $123,720 to $357,930. In contrast, DME billing represents a smaller volume and rose steadily, from $260 to $5,904.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	121	462	$19,021
2021	404	1,646	$67,415
2022	510	2,519	$104,679
2023	681	3,677	$142,741
2024	779	5,629	$180,168

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	295	1,938	$123,720
2016	256	1,718	$113,273
2017	403	2,481	$157,740
2018	353	2,400	$184,283
2019	382	2,311	$182,053
2020	218	878	$82,414
2021	252	1,605	$121,292
2022	457	2,730	$237,087
2023	435	3,773	$417,271
2024	487	4,451	$357,930

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	26	$309
2017	N/R	38	$457
2018	11	32	$427
2019	N/R	15	$169
2020	11	16	$196
2021	N/R	N/R	N/R
2022	N/R	33	$5,779
2023	N/R	75	$3,751
2024	N/R	56	$4,386

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	174	174	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	294	531	$82
80061	Blood test, lipids (cholesterol and triglycerides)	282	325	$13
36415	Insertion of needle into vein for collection of blood sample	437	715	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	243	322	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	79	4,935	$90,228
Trulicity	Dulaglutide	26	1,288	$40,016
Xarelto	Rivaroxaban	12	960	$16,992
Ozempic	Semaglutide	17	644	$16,098
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	1,068	$8,947

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	14	$3,633
E0630	Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)	Y	N/R	11	$411
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	20	$293
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	N	N/R	11	$48

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Sarah Tsang, MD?

Tedicare shows public-source Medicare data for Sarah Tsang, MD (NPI 1225368087), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sarah Tsang, MD have ACO affiliation data?

Sarah Tsang, MD is shown with ACO affiliation data for Pioneer Valley Accountable Care, LLC (MSSP, ACO ID A5040) and C3 MSSP LLC (MSSP, ACO ID A5344).

What billing organization is linked to Sarah Tsang, MD?

Sarah Tsang, MD is linked to VALLEY MEDICAL GROUP, P.C. (billing NPI 1912924705) in the available physician profile data.

Does Sarah Tsang, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.